CryoLife Inc (CRY) - Product Pipeline Analysis, 2021 Update

CryoLife Inc (CryoLife) is a medical device company that manufactures and distributes biosurgical devices and implantable human tissues for cardiac and vascular surgical procedures for treatment of aortic disease. The company’s portfolio enlists preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, bovine pericardium, and mitral chordal repair products, photofix products and Jotec products. The company products serve physicians, cardiac surgeons, hospitals, and medical institutions. The company has manufacturing facilities in Texas and Georgia in the US and Hechinger, Germany. The company distributes its products through a network of direct sales force in the UK, Austria, France, Germany, Ireland and Switzerland, and independent distributors in the rest of Europe, the Middle East, and Africa. It commercializes products in more than 85 countries across the worldwide. The company is headquartered in Atlanta, Georgia, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

• The report analyzes all pipeline products in development for the company CryoLife Inc
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company